New and Noteworthy

Showing 9 of 0 results

• Carfilzomib prescribing patterns and outcomes for relapsed or refractory multiple myeloma: a real-world analysis

  Blood Cancer Journal

  • Publication summary
  • Publications
  • Clinical decision support
  • Treatment patterns
  • Multiple myeloma
• With real-world evidence, the whole is greater than the sum of its parts
  • Real-world evidence
  • Case study
• From data to decisions: the role of real-world evidence in recent multiple myeloma drug approvals in the US and EU

  ISPOR

  • Real-world evidence
  • Publication summary
  • Publications
  • Regulatory
• Leveraging machine learning to assess the association of rash and survival in patients with advanced NSCLC

  ISPOR

  • Real-world evidence
  • Publication summary
  • Publications
  • Machine learning
• Performance assessment and validation of real-world response data generated using a deep learning-based natural language processing model across multiple solid tumors

  ISPOR

  • Real-world evidence
  • Publication summary
  • Publications
  • Machine learning
• Analytical approaches to estimate medication persistence from EHR data: a study of TKIs in patients with EGFR+ advanced NSCLC

  ISPOR

  • Real-world evidence
  • Publication summary
  • Publications
  • Methodology
  • Non-small cell lung cancer
• Augmenting race and ethnicity in a real-world oncology cohort using the Bayesian improved surname geocoding methodology

  ISPOR

  • Real-world evidence
  • Publication summary
  • Publications
• Advancing breast cancer research in Japan using EHR-derived real-world data

  ISPOR

  • Real-world evidence
  • Publication summary
  • Publications
  • Machine learning
• Patient characteristics and treatment patterns in extensive-stage small cell lung cancer (ES-SCLC)

  ISPOR

  • Publication summary
  • Publications
  • Machine learning
  • Small cell lung cancer